[HTML][HTML] Implication of microRNAs in carcinogenesis with emphasis on hematological malignancies and clinical translation

Z Gaál - International Journal of Molecular Sciences, 2022 - mdpi.com
MicroRNAs (miRNAs) are evolutionarily conserved small non-coding RNAs, that are
involved in the multistep process of carcinogenesis, contributing to all established hallmarks …

[HTML][HTML] Epigenetic Alterations in Canine Malignant Lymphoma: Future and Clinical Outcomes

E Montaner-Angoiti, PJ Marín-García, L Llobat - Animals, 2023 - mdpi.com
Simple Summary Canine malignant lymphoma is one of the most common neoplasias in
dogs. Even though breed influences the prevalence and prognosis, most cases present …

[HTML][HTML] Molecular techniques drive cutting edge advancements in management of cutaneous T cell lymphoma

MN Lefebvre, N Borcherding, RJ Reis, E Mou… - Frontiers in …, 2023 - frontiersin.org
Cutaneous 5T cell lymphoma (CTCL), characterized by malignant T cells infiltrating the skin
with potential for dissemination, remains a challenging disease to diagnose and treat due to …

[HTML][HTML] Epigenetic modulation of the tumor immune microenvironment by nanoinducers to potentiate cancer immunotherapy

N Zhang, X Hao - Cancer Biology & Medicine, 2022 - ncbi.nlm.nih.gov
Epigenetic dysregulation is a key factor leading to oncogenesis and tumor progression 1. To
date, seven agents in three epigenetic target classes have been approved by the US Food …

[HTML][HTML] PGD2 displays distinct effects in diffuse large B-cell lymphoma depending on different concentrations

S Hu, T Lu, J Shang, Y Cai, M Ding, X Zhou… - Cell Death …, 2023 - nature.com
Abstract Prostaglandin D2 (PGD2), an arachidonic acid metabolite, has been implicated in
allergic responses, parasitic infection and tumor development. The biological functions and …

Emerging drugs for the treatment of cutaneous T-cell lymphoma

M Cheng, J Zain, ST Rosen… - Expert opinion on …, 2022 - Taylor & Francis
Introduction Cutaneous T cell lymphoma (CTCL) is a rare and incurable group of non-
Hodgkin lymphomas that manifest as patches, plaques, tumors, and/or erythroderma in the …

[HTML][HTML] Single-cell analyses reveal novel molecular signatures and pathogenesis in cutaneous T cell lymphoma

X Xue, Z Wang, Z Mi, T Liu, C Wang, P Shi, L Sun… - Cell Death & …, 2022 - nature.com
Sézary syndrome (SS) is a rare and aggressive type of cutaneous T cell lymphoma (CTCL)
with a poor prognosis. Intra-tumoral heterogeneity caused by different disease …

Non-coding RNAs in the epigenetic landscape of cutaneous T-cell lymphoma.

M Adeeb, L Therachiyil, S Moton… - … Review of Cell and …, 2023 - europepmc.org
Cutaneous T-cell lymphoma (CTCL) is a type of cancer that affects skin, and is characterized
by abnormal T-cells in the skin. Epigenetic changes have been found to play a significant …

[HTML][HTML] DOT1L inhibition does not modify the sensitivity of cutaneous T cell lymphoma to pan-HDAC inhibitors in vitro

EM Kwesi-Maliepaard, M Malik, T van Welsem… - Frontiers in …, 2022 - frontiersin.org
Cutaneous T-cell lymphomas (CTCLs) are a subset of T-cell malignancies presenting in the
skin. The treatment options for CTCL, in particular in advanced stages, are limited. One of …

Epigenetics and cutaneous neoplasms: from mechanism to therapy

F Gibson, A Hanly, R Fisher, WA Wyant, M Wu… - …, 2023 - Future Medicine
Epigenetics encompasses heritable, reversible gene expression patterns that do not arise
from mutations in genomic DNA but, rather, are regulated by DNA methylation, histone …